MCGAULEY THOMAS
SEC insider (Form 3/4/5 filer). CIK 0001550701. Interim CFO at TENAX THERAPEUTICS, INC. (TENX). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 30, 2026. Located in CHAPEL HILL, NC.
Companies MCGAULEY THOMAS has filed insider reports for
- TENAX THERAPEUTICS, INC. (TENX): Officer, Interim CFO
MCGAULEY THOMAS
CIK: 0001550701
Transaction Breakdown
Open Market Buys (P)3 (75.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TENX
TENAX THERAPEUTICS, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 30, 2026TENX
TENAX THERAPEUTICS, INC.
ExerciseDirectStock Option (right to buy)
50K shares- - Nov 17, 2025TENX
TENAX THERAPEUTICS, INC.
PurchaseDirect2K shares at avg. $7.34$15K - Nov 17, 2025TENX
TENAX THERAPEUTICS, INC.
PurchaseIndirect1K shares at avg. $7.35$7K - Nov 17, 2025TENX
TENAX THERAPEUTICS, INC.
PurchaseIndirect5K shares at avg. $7.23$36K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 30, 2026 | TENX TENAX THERAPEUTICS, INC. | Exercise Stock Option (right to buy) | 50,000 | - | - | Direct |
| Nov 17, 2025 | TENX TENAX THERAPEUTICS, INC. | Purchase | 2,000 | $7.34 | $14,674 | Direct |
| Nov 17, 2025 | TENX TENAX THERAPEUTICS, INC. | Purchase | 1,000 | $7.35 | $7,350 | Indirect |
| Nov 17, 2025 | TENX TENAX THERAPEUTICS, INC. | Purchase | 5,000 | $7.23 | $36,140 | Indirect |
1-4 of 4 transactions